Skip to content

Bausch Health

US · BHC #2722 by market cap Listed 1970
8.22 -0.34 -3.97%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:46

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions increased by 11 in the most recent period (2026/Q3).
  • Total institutional ownership fell 1.1 percentage points.

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
64.88% -1.05pp
Institutions
263 +11
As of
2026/Q3 vs. prior period

Holder types

Hedge Fund37.33%
Mutual Fund16.43%
Individual/Insider10.71%
Public Company4.10%
Government Pension Fund2.54%
Private Company2.02%
VC/PE Fund1.40%
Sovereign Wealth Fund0.94%
Other24.43%

Top holders as of 2026-06-30

Paulson & Co. Inc. 19.57% · 73.26M sh
Alexander Meruelo 9.76% · 36.54M sh
GoldenTree Asset Management LP 9.26% · 34.67M sh
Healthcare of Ontario Pension Plan Trust Fund 2.14% · 8.00M sh
Vanguard Capital Management, LLC 1.99% · 7.44M sh
Acadian Asset Management LLC 1.93% · 7.24M sh
The Goldman Sachs Group, Inc. 1.62% · 6.07M sh
MFN Partners Management, LP 1.60% · 6.00M sh
SG Americas Securities, LLC 1.48% · 5.54M sh
KKR & Co. Inc. 1.40% · 5.24M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 31 buys · 19 sells

NameRoleStake
Paulson & Co. Inc. -- 19.57%
Thomas Appio Chief Executive Officer 0.23%
Seana Carson Executive Vice President 0.19%
Jean-Jacques Charhon Chief Financial Officer 0.05%
Amy Wechsler Independent Director 0.03%
Christian Garcia Independent Director 0.02%
Sandra Leung Independent Director 0.01%
Frank Lee Independent Director 0.01%
Aimee Lenar President of US Pharma 0.01%
Robert Power Independent Director 0.00%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-29 Sandra Leung Independent Director Other Acquisition +5,789 $5.83
2026-09-29 John Paulson Independent Chairperson Other Acquisition +10,720 $5.83
2026-09-29 Amy Wechsler Independent Director Other Acquisition +1,179 $5.83
2026-08-18 Aimee Lenar President of US Pharma Automatic Disposition -36,827 $7.03
2026-07-16 Aimee Lenar President of US Pharma Sale to Issuer -5,260 $4.83
2026-07-14 Aimee Lenar President of US Pharma Sale to Issuer -23,395 $4.89
2026-07-13 Steven Lee -- Sale to Issuer -3,125 $4.75
2026-06-29 Sandra Leung Independent Director Other Acquisition +6,845 $4.93
2026-06-29 John Paulson Independent Chairperson Other Acquisition +12,677 $4.93
2026-06-29 Amy Wechsler Independent Director Other Acquisition +1,394 $4.93
2026-05-21 Sandra Leung Independent Director Other Acquisition +45,871 --
2026-05-21 John Paulson Independent Chairperson Other Acquisition +45,871 --
2026-05-21 Robert Power Independent Director Other Acquisition +45,871 --
2026-05-21 Sarah Kavanagh Independent Director Other Acquisition +45,871 --
2026-05-21 Christian Garcia Independent Director Other Acquisition +45,871 --
2026-05-21 Amy Wechsler Independent Director Other Acquisition +45,871 --
2026-05-21 Eiry Roberts Independent Director Other Acquisition +45,871 --
2026-05-21 Michael Goettler Former Independent Director Other Acquisition +45,871 --
2026-05-21 Frank Lee Independent Director Other Acquisition +45,871 --
2026-05-18 Frank Lee Independent Director Automatic Disposition -24,456 $5.43

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:46:13 · For reference only, not investment advice and not tailored to your situation.

Bausch Health discussion 0 comments

Add a comment